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Abstract
Objectives
The purpose of our study was to assess proton density (PD) and T2 relaxation time of usual
interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP) and to evaluate their
utility in differentiating the two patterns. Furthermore, we aim to investigate whether these two
parameters could help differentiate active-inflammatory and stable-fibrotic lesions in NSIP.
Methods
32 patients (mean age: 69 years; M:F, 1:1) with pathologically proven disease (UIP:NSIP,
1:1), underwent thoracic thin-section multislice CT scan and 1.5T MRI. A total of 437 regions-
of-interest (ROIs) were classified at CT as advanced, moderate or mild alterations. Based on
multi-echo single-shot TSE sequence acquired at five echo times, with breath-holding at end-
expiration and ECG-triggering, entire lung T2 and PD maps were generated from each sub-
ject. The T2 relaxation time and the respective signal intensity were quantified by performing
a ROI measurement on the T2 and PD maps in the corresponding CT selected areas of the
lung.
Results
UIP and NSIP regional patterns could not be differentiated by T2 relaxation times or PD val-
ues alone. Overall, a strong positive correlation was found between T2 relaxation and PD in
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NSIP, r = 0.64, p<0.001; however, this correlation was weak in UIP, r = 0.20, p = 0.01. T2
relaxation showed significant statistical difference between active-inflammatory and stable-
fibrotic NSIP regions at all levels, p<0.05, while for the analysis of ventral lesions PD proved
no statistical difference, p>0.05.
Conclusions
T2 relaxation times and PD values may provide helpful quantitative information for differenti-
ating NSIP from UIP pattern. These parameters have the potential to differentiate active-
inflammatory and stable-fibrotic lesions in NSIP.
Introduction
Interstitial lung diseases comprise a group of diffuse parenchymal pulmonary diseases that are
classified together due to their similar clinical, radiologic, physiologic, and/or pathologic mani-
festations [1]. The new ATS/ERS/JRS/ALAT guidelines for idiopathic pulmonary fibrosis pro-
vide criteria to define the usual interstitial pneumonia (UIP) pattern, possible UIP pattern, and
patterns inconsistent with UIP on HRCT [2]. Idiopathic nonspecific interstitial pneumonia
(NSIP) was accepted as a subtype in 2008 [3], after Katzenstein and Fiorelli introduced the
term for those cases of interstitial pneumonia that cannot be pathologically categorized as
another type of idiopathic interstitial pneumonia [4]. The radiological patterns of UIP and
some NSIP may share criteria for possible UIP pattern. Moreover, a recent review proposed
that when a possible UIP pattern is identified, the clinical problem most frequently encoun-
tered is to distinguish UIP from NSIP [5].
In idiopathic disease, with the exception that patients displaying NSIP pattern are more
commonly female and generally have a younger mean age than those exhibiting UIP pattern
[6], there is substantial overlap in the clinical and physiologic features between the two forms,
both presenting insidious onset of dyspnea, dry cough and a restrictive ventilatory defect [7].
The recommended therapy and overall prognosis are distinct, however, making accurate
diagnosis of this two entities critical [8,9]. Progressive deterioration of lung function and early
death are specific for UIP pattern, regardless of its cause (idiopathic or connective tissue
related [10])–idiopathic pulmonary fibrosis carries the worst prognosis, with a 5-year survival
of approximately 30% [11]. On the other hand, for NSIP stabilization or improvement is more
characteristic [12].
Several reports have shown that, in some cases, the differential diagnosis between UIP and
NSIP by CT alone is not always straightforward, requiring additional surgical lung biopsy [13–
19]. However, lung biopsy carries some risk and morbidity [20,21], therefore the identification
of patients with UIP or NSIP by a noninvasive procedure, such as thoracic MRI, would prove
to be a valuable clinical resource. Yet, to date and to the best of our knowledge no study has
attempted to provide relevant evidence in this matter using MRI techniques.
Moreover, despite its importance for therapy decision-making and for prediction of treat-
ment response, the radiological distinction between active-inflammatory and stable-fibrotic
lesions in NSIP remains challenging. The feasibility of measuring lung water content and dis-
tribution by MRI techniques has been well recognized since the 1980s [22–25]. However, so
far quantitative techniques such as T2 relaxation and PD for inflammatory activity assessment
in chronic interstitial lung disease have only been performed on animal models of bleomycin
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induced fibrosis [26–28]. We aim to investigate for the first time the clinical utility of these
methods applied to a cohort of patients with NSIP using a clinical 1.5T MRI scanner.
Giving the histological differences between UIP and NSIP [1], we hypothesized that an
analysis using quantitative MRI parameters such as T2 relaxation times and proton density
(PD) values may reveal specific features of lung microstructure valuable for the distinction of
UIP and NSIP. The purpose of our study was to assess PD and T2 relaxation of UIP and NSIP
and to evaluate their utility in differentiating the two patterns. Furthermore, we aim to investi-
gate whether these two parameters could help differentiate active-inflammatory and stable-
fibrotic lesions in NSIP.
Materials and methods
Patients
This cross-sectional prospective study included 34 patients who displayed an UIP or NSIP pat-
tern, between January 2014 and February 2015. The ethics committee of the University of Hei-
delberg approved this study (clearance number S-318/2013). Written informed consent was
obtained from each patient before performing the study examinations. The inclusion criterion
was that the patient had pathologically confirmed UIP or NSIP pattern. All patients underwent
thoracic thin-section multislice CT scan and 1.5T MRI. Two patients were excluded because at
least one of the two examinations was incomplete. Informed consent was obtained from each
patient.
The 32 patients included were 16 males and 16 females, with a mean age of 69 years (range
40–81 years). All diagnoses were made, according to current guidelines, by consensus in a
multidisciplinary meeting, after reviewing the clinical findings, results of pulmonary function
and laboratory tests, thin-section CT scan and biopsy reports. There were 16 UIP cases (14 idi-
opathic pulmonary fibrosis and 2 connective tissue disease-related UIP) and 16 NSIP patients
(7 idiopathic and 9 with connective tissue disease-related NSIP; 8 with suspected inflammatory
activity and 8 with stable disease). The current clinical presentation, pulmonary function tests
and thin-section CT scan were used in all cases to categorize patients as having stable disease
or suspected inflammatory activity. Stable disease was considered when there was no interval
change in clinical presentation, pulmonary function tests and CT appearances from the previ-
ous assessment. Patients with suspected inflammatory activity presented with sudden worsen-
ing in symptomatology and pulmonary function tests. Possible infection was excluded
clinically and the patients underwent chest CT. When ground glass opacities were noted an
additional MRI of the lung was performed during the same day (6 cases), the subsequent day
(1 case), and the second day after the CT scan (1 case). Twelve patients were previously
included in a study analyzing the T2 relaxation time of different CT patterns in interstitial
lung disease [29].
CT imaging
The thin-section MDCT examinations were performed using a 64-detector CT system (Soma-
tom Definition AS, Siemens Medical Systems, Erlangen, Germany), with scans obtained from
the lung apex to the diaphragm, during breath-holding at the end of full inspiration. The heli-
cal scan protocol applied was: 64×0.6 mm collimation, 1.5 pitch, 0.33 s/rotation, 300–330 mm
field of view, 512×512 matrix, 120 kV, 70 mAs. Reconstructions of all thin-section CT images
were performed as contiguous slices of 1.0 mm thickness by means of a standard iterative algo-
rithm (I40) and a lung iterative algorithm (I70).
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MR imaging
MRI was performed on a clinical 1.5-T MR whole-body unit (Magnetom Aera, Siemens Medi-
cal Systems, Erlangen, Germany). Entire lung T2 sagittal maps were generated based on multi-
echo single shot turbo spin echo sequences [TE: 20, 40, 79, 140, 179 ms, each acquisition: 30
slices of 10 mm thickness and 3.125x3.125 mm pixel size (matrix: 104×128)], as described in a
previous article [29]. A nonrigid image registration [30], using the first acquisition (TE = 20ms)
as reference image, was applied to correct for residual motion mismatch between the volumes
at different TE. PD intensity maps, representing the approximation of the MR signal intensity
in the limit TE!0, were automatically produced from the acquired data set, together with the
T2 maps, using the commercial mapping tool pack provided by the MR system post-processing
software.
Image analysis and statistics
One thoracic radiologist (with >5 years of experience) defined the reference images and repre-
sentative regions of interest (ROIs) while reviewing the CT scans. The ROIs exhibited different
degrees of regional parenchymal impairment, according to the density of fibrosis on CT
images and presence of parenchymal architectural distortion (lung volume loss, bronchiectasis
or scaring), as follows: advanced fibrosis with marked architectural distortion (dense fibrosis
with severe lung volume loss and traction bronchiectasis, honeycombing or complete scaring),
moderate disease including reticulation with or without architectural distortion, and mild
alterations consisting of ground-glass opacities with minimal or no architectural distortion.
Honeycombing, reticulation and ground-glass opacities were defined according to the Fleisch-
ner Society nomenclature [31]. When a mixture of reticulation and ground glass opacity was
present, the region was included in the moderate disease category. The number of measure-
ments per patient was dependent on the extent of the disease and the extent of each regional
pattern.
The same radiologist involved in ROI definition quantified the T2 relaxation time on the
T2 maps and the respective signal intensities on PD maps, by performing a ROI measurement
in the corresponding CT selected areas of the lung. A circular or ovoid ROI was drawn as large
as possible to cover an area of>100 mm2 and was placed to avoid lesion borders to reduce par-
tial volume-averaging effects. Moreover, the ROI was positioned to avoid large blood vessels
and main airways. In order to minimize the clustering effect, only one ROI was selected for a
specific type of lesion on each map, or, if the same pattern was extensively present on the same
image, the different ROIs were chosen from distinct lung lobes.
Data normalization on the PD measurements was performed to correct for the signal
gain variability, using the spleen intensity value as a reference for each patient, since we
assumed this organ should have the most constant assessment between patients and none of
our patients had a diagnosis of splenic disease. Because the T2 relaxation time of ground-
glass opacities and reticulation seems to be different between the two lungs [29] and PD
should be affected by gravity, the analysis for each type of lesion was done according to
ROI’s topology.
Statistical analysis was performed using R statistical software version 2.15.1 (R Foundation
for Statistical Computing, Vienna, Austria). Continuous variables were summarized using
median [interquartile range]. The Wilcoxon rank sum test was used to assess the differences
between the selected types of lesions. The correlation between the PD intensity values and T2
relaxation times of stable disease was evaluated by Spearman rank correlation test. All proba-
bility values were 2-sided, with a level of significance of<0.05.
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Results
The findings in both imaging techniques correlated well on the one-to-one analysis between
CT and MR images and ROIs and all 32 patients tolerated well the examination. A total of 437
ROIs, with a median [interquartile] of 13 [10–17] selected sites per patient, were CT classified
into advanced (n = 175), moderate (n = 160) and mild (n = 102) lesions. Further details about
the number of measurements for each type of regional severity within the overall CT pattern
are presented in Tables 1 and 2.
The same tables show the median and interquartile range of T2 relaxation time and PD
respectively, for the three types of lesions according to their localization. No significant statisti-
cal difference was found between stable UIP and stable NSIP regarding T2 relaxation times, at
any of the analyzed levels, with the exception of moderate disease in the right lung, p<0.01. No
significant statistical difference was found between stable UIP and stable NSIP regarding PD,
at any of the analyzed levels, with the exception of advanced disease with dorsal localization,
where NSIP show significantly higher values as compared to UIP, p<0.001. For dorsal lesions,
a strong positive correlation was found between T2 relaxation and PD in stable NSIP, r = 0.64,
p<0.001; however, this correlation was weak in stable UIP, r = 0.20, p = 0.01.
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In NSIP, a strong statistical difference was present between the PD intensity values in active
vs. stable disease for both mild and moderate lesions with dorsal localization, p<0.0001, but
not for ventral lesions, p>0.05. A significant statistical difference was found between the T2
relaxation time of active-inflammatory vs. stable-fibrotic alterations at all levels, including ven-
tral lesions, p<0.05. Fig 1 shows two CT morphological similar cases for comparison of active-
inflammatory and stable-fibrotic mild alterations in NSIP.
Discussion
In this prospective study, we presented, to the best of our knowledge, the first quantitative
MRI description, using T2 relaxation times and PD values, in patients with pathologically
proven UIP and NSIP. Furthermore we have investigated for the first time the clinical utility of
these parameters for differentiating active-inflammatory from stable-fibrotic lesions, applied
on a cohort of patients with NSIP using a clinical 1.5T MRI scanner.
Fig 1. A 59 year old male patient with stable NSIP: image A is the sagittal reformat CT reference image, with the arrow indicating the region of interest,
followed by the T2 map, image B and PD intensity map, image C. Below is the case of a 65 year old male patient with NSIP and suspected inflammatory
activity and his corresponding images, D to F. Both cases show similar CT morphology and inhomogeneous T2 relaxation and PD of the lung; there is higher
T2 relaxation and PD intensity on both type of maps in the active disease case. Exemplary ROI placement in relevant pathological areas is demonstrated.
https://doi.org/10.1371/journal.pone.0177689.g001
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UIP and NSIP regional patterns could not be differentiated by T2 relaxation times or PD
intensity measurements individually. Yet, there seems to be a mismatch between the T2 relaxa-
tion time and PD values in stable UIP, whereas there appears to be a good correlation between
the two in stable NSIP. Moreover, patients with NSIP and suspected inflammatory activity
show significantly higher T2 relaxation times and PD values than those with stable disease.
However, T2 relaxation seems to be a more reliable parameter since for the analysis of ventral
lesions PD proved no statistical difference.
Regarding T2 relaxation time, the only statistically significant difference we found between
UIP and NSIP at regional level was for moderate alterations in the right lung. Suzuki et al.
reported a significant difference between the supine and prone positions in the right lung at
normal breathing of room air, but not for the left lung, in healthy subjects [32]. The authors’
explanation was that the right lung, having a greater volume and weight, may be more influ-
enced by gravity than the left lung. In our study, the higher values in moderate UIP lesions
might be due to a greater degree of perivascular fibrosis in NSIP [33], leading to hypoxic vaso-
constriction and lower amount of blood in the affected region. However, no such difference
was found regarding mild changes. We assume that the mild alterations were insufficient to
produce significant blood volume changes in the analyzed regions, therefore not enough T2
relaxation differences.
Regarding PD, we found a statistically significant difference between UIP and NSIP only
for advanced lesions with dorsal localization, UIP showing lower values in this case. This
might be due to the presence of air-containing honeycombing lesions (micro- and macro-
cysts) which decrease the mean proton density in the region.
The histopathologic hallmark of UIP is spatial heterogeneity, which refers to a patchy distri-
bution of dense parenchymal scar alternating with areas of less affected or normal parenchyma
[1]. The histologic abnormalities are based on temporal heterogeneity, reflecting different
stages in the evolution of fibrosis within the same biopsy specimen [6]. In contrast to UIP,
NSIP is characterized by relative spatial homogeneity of parenchymal lung involvement and
by temporal homogeneity of the injury (inflammation and/or fibrosis) [1]. Fibrosis may be
masked by partial volume averaging effects form healthy or less affected lung parenchyma,
resulting in lower averaged PD values. However, this is unlikely in NSIP due to its spatial
homogeneity and might have led to the strong positive correlation we found between T2 relax-
ation and PD in stable NSIP, and the rather weak one in stable UIP. Some of our ROI measure-
ments present outlying values probably due to presence of certain areas inconsistent with the
general pattern. Some studies revealed that different patterns of lung injury can be found in
different lobes within the same lung or even within the same lobe [5]. We found 9 ROIs with
marked outlying values in 3 patients with idiopathic NSIP. While reviewing the data, we
observed that the selected ROIs were classified as advanced disease. We believe this finding is
consistent with Silva et al. [16], who found that patients with idiopathic NSIP can progress to
an UIP pattern at long-term follow-up. Further studies on larger cohorts are needed to further
validate our findings, while extending the analysis by including other types of chronic ILD
such as hypersensitivity pneumonitis.
The distinction between active-inflammatory and stable-fibrotic lesions is considered a
major determinant of treatment response and long-term survival rate. On high-resolution CT,
active inflammation and fibrotic lesions may present similar morphology [34]. MRI is gener-
ally expected to facilitate differentiation of active-inflammatory and stable-fibrotic lesions,
with the advantage of being non-irradiating and noninvasive. The presence of high signal
intensity lesions proved to be a useful predictor of treatment response and clinical outcome
[35], while subsequent studies showed that regions with active inflammation had prominent
enhancement, whereas fibrotic lesions did not [34].
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T2 mapping proved useful in the assessment of edema in myocardial infarction and acute
myocarditis, and of hypokinetic regions in Takotsubo cardiomyopathy; furthermore, it may
improve detection of cardiac sarcoidosis [36]. Lung T2 has been observed to increase in experi-
mental pulmonary edema and has been found to correlate well with gravimetric measurement
of lung water content [25]. Furthermore, the T2 relaxation time and proton density are com-
plementary parameters in the assessment of lung water accumulation of different origins [25].
Our study shows that active-inflammatory lesions have high T2 relaxation times and PD values
and these parameters could allow for regional quantification of inflammation. However, T2
relaxation seems to be a more reliable parameter. T2 relaxation showed significant statistical
difference between active-inflammatory and stable-fibrotic NSIP lesions at all levels, while, for
the analysis of ventral lesions, PD proved no statistical difference. Despite that the values of
inflammatory lesions overlap with those of advanced fibrosis, the two can be morphologically
differentiated on thin-section CT scans. Moreover, giving that fibrotic lesions are less affected
by gravity [29], an additional examination in supine may prove valuable in the further differ-
entiation of stable-fibrotic and active-inflammatory lesions, the latter being under the influ-
ence of gravity effects due to the free water content.
Our findings suggest that further research on monitoring of these patients, with additional
discussion concerning cutoff values, is warranted. Follow-up studies have shown only minor
changes on HRCT, at visual assessment, in the first 6 months after diagnosis, but progressive
increase in the extent of fibrotic lesions at 1 year or more from initial diagnosis [11]. Recently,
we used another approach, by means of both visual assessment and a fully automatic histo-
gram-based quantitative evaluation, to follow-up IPF patients at 1 year interval, and found
substantial difference in Hounsfield unit changes of the 40th (representing mostly ground-
glass opacities) and of the 80th (representing mostly reticulation) percentiles of density histo-
gram between treated and untreated patients [37]. Giving that T2 relaxation times and PD val-
ues are dependent on water content and density of fibrotic tissue, we expect some earlier
changes at a local level, leading to increase of the two parameters values with disease progres-
sion and decrease with response to treatment. Such quantitative methods may prove useful in
future studies concerning follow-up of these patients and assessment of treatment response in
clinical trials. Shin et al. [38] showed that a high fibrotic score and a low carbon monoxide dif-
fusing capacity of the lung appear to be significant independent predictive factors of poor sur-
vival in patients with fibrotic idiopathic interstitial pneumonia. Our quantitative evaluation
shows increased T2 relaxation times both in advanced fibrosis and inflammatory lesions,
anticipating possible prognostic implications.
Our study is subject to several limitations. First, the study included only cases with histolog-
ical UIP or NSIP and this fact might have contributed to selection bias of cases with atypical
disease. Still, this setting is more comparable to clinical practice where typical cases can be
diagnosed with CT or through a multidisciplinary approach, without the need of biopsy or
advanced imaging. Second, we do not have a recent biopsy for the accurate diagnosis of
inflammatory activity. Such a procedure could not be justified in patients who previously
underwent a histological diagnosis of their disease due to the increased risk of exacerbation.
Third, we chose several ROIs from a single patient in order to have as many measurements for
each type of lesion as possible. On the other hand this lead to each patient contributing differ-
ent numbers of ROIs within the mild, moderate or severe lesion groups. These facts may cause
clustering effects that affect the results. However, we adjusted our analysis accordingly and the
overall large number of ROIs included (n = 437) should minimize this possible source of error.
Moreover, the severity of lesions was very broad, particularly in NSIP stable patients, and
patients with honeycombing contributed not only for severe lesions but also for mild or mod-
erate lesion if reticulation or ground glass opacities were present in a slice. Another limitation
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is that comorbidities, which are frequent in idiopathic pulmonary fibrosis (e.g. pulmonary
hypertension) [39], could have influenced the findings. In the present study, we aimed to find
differences between UIP and NSIP pattern, and between active-inflammatory and stable-
fibrotic lesions, respectively. Further analysis will be needed on larger patient cohorts to assess
possible effects of comorbidities that might influence the results.
Conclusions
The correlation between T2 relaxation times and PD values may prove helpful in differentiat-
ing NSIP from UIP pattern, thus decrease the amount of pathologically confirmed NSIP or
UIP pattern. The described quantitative MRI methods have the potential to differentiate
active-inflammatory and stable-fibrotic lesions in NSIP, therefore possibly allowing for a better
stratification of patients who might benefit from immunomodulatory therapy.
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